- 優先名称
- Spartanamicin A
- IUPAC
- methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-(dimethylamino)-5-[[(1R,3R,5R,8S,10S,12S,14S)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.03,8]tetradecan-12-yl]oxy]-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
- 現地名
- スパルタナマイシンA
- 英語名
- Spartanamicin A
- 分子式
- C42H51NO16
- 分子量
- 825.86
名称と別名
Spartanamicin A104759-19-5Antibiotic sipi 80334-BRefChem:932006Antibiotic 80334 BMethyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-(dimethylamino)-5-[[(1R,3R,5R,8S,10S,12S,14S)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.03,8]tetradecan-12-yl]oxy]-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate1-Naphthacenecarboxylic acid, 4-(((2''',3''-anhydro)-O-3,6-dideoxy-beta-D-threo-hexopyranos-4-ulos-1-yl-(1-4)-O-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl-(1-4)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester, (1R-(1alpha,2beta,4beta))-(1R)-4α-[4-O-[[(2S,4aα,5aβ,9aβ,10aα)-2β,9α-ジメチルオクタヒドロ-4-オキソ-2H,9H-ジピラノ[2,3-b:4′,3′-e][1,4]ジオキシン]-7β-イル]-2,3,6-トリデオキシ-3-(ジメチルアミノ)-α-L-lyxo-ヘキソピラノシルオキシ]-2-エチル-1,2,3,4,6,11-ヘキサヒドロ-2α,5,7,10-テトラヒドロキシ-6,11-ジオキソ-1β-ナフタセンカルボン酸メチルメチル (1R,2R,4S)-4-{[(2R,4S,5S,6S)-5-{[(1S,3R,5S,8S,10R,12R,14R)-5,14-ジメチル-7-オキソ-2,4,9,13-テトラオキサトリシクロ[8.4.0.03,8]テトラデカン-12-イル]オキシ}-4-(ジメチルアミノ)-6-メチルオキサン-2-イル]オキシ}-2-エチル-2,5,7,10-テトラヒドロキシ-6,11-ジオキソ-1,2,3,4,6,11-ヘキサヒドロテトラセン-1-カルボキシラート